Better Therapeutics, Inc. (NASDAQ: BTTX) reported Q1 EPS of ($0.37), $0.13 better than the analyst estimate of ($0.50). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on Better Therapeutics, Inc. (BTTX) click here.